The IL-22 levels in serum and follicle fluid of patients with PCOS decreased, whereas the IL-22 administration could improve IR, ovarian dysfunction, dysbiosis of gut microbiota, and prenatal Müllerian hormone in the DHEA-induced PCOS mice (86). The gene discussed is IL22; the disease is polycystic ovary syndrome.